Diets
ketogenic diet decreases hepatic steatosis liver fat in MASLD/NAFLD
In plain terms: Does the ketogenic diet reduce liver fat in fatty-liver disease (MASLD/NAFLD)?
Part of: 🥗 ketogenic diet
Yes in the short term — very-low-energy keto reduces hepatic steatosis, though this tracks closely with the weight loss it causes rather than being uniquely ketogenic.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Very-low-energy ketogenic diets do reduce liver fat in the short term, shown both isotopically and against standard low-calorie comparators. The caveat is attribution: the effect tracks the weight loss closely, one randomised trial found the improvements mediated by weight rather than ketosis, and the supporting studies are small and often uncontrolled.
The evidence (15)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Luukkonen PK, Dufour S, Lyu K, Zhang XM, Hakkarainen A, Lehtimäki TE, Cline GW, Petersen KF, Shulman GI, Yki-Järvinen H 2020 · Proc Natl Acad Sci U S A | observational | supports | moderate | Human isotope study showed a ketogenic diet rapidly reduced intrahepatic triglyceride via increased hepatic fat oxidation. |
| Schiavo L, Pierro R, Asteria C, Calabrese P, Di Biasio A, Coluzzi I, Severino L, Giovanelli A, Pilone V, Silecchia G 2022 · Obes Surg | RCT | tested-null | low | Low-calorie ketogenic diet improved lipids, CRP and blood pressure via weight loss in obese OSAS patients, implicating calorie/weight loss rather than ketosis per se as the driver. |
| Cunha GM, Guzman G, Correa De Mello LL, Trein B, Spina L, Bussade I, Marques Prata J, Sajoux I, Countinho W 2020 · Front Endocrinol | RCT | supports | low | 2-month very-low-calorie ketogenic diet reduced visceral and liver fat more than a standard low-calorie diet in patients with obesity. |
| Saslow LR, Krinock J, O'Brien A, Raymond K, Bayandorian H, Moskowitz JT, Daubenmier J, Oliveri A, Marriott DJ, Griauzde DH, Speliotes EK 2025 · JMIR Formative Research | observational | mixed | low | Pre-post pilot (no comparator arm), n=11 enrolled / 9 completed with liver-fat data, very-low-carbohydrate diet in PNPLA3 (rs738409) risk-genotype MASLD adults over 4 months; hepatic liver fat percent change -33.2% overall (95% CI -86.5 to |
| Haghighatdoost F, Salehi-Abargouei A, Surkan PJ, Azadbakht L 2016 · Clin Nutr | meta-analysis | supports | low | Meta-analysis found low-carb diets improved some liver measures but intrahepatic-lipid effects were inconsistent across trials. |
| Qadri SF, Porthan K, Dufour S, Lehtimäki TE, Petersen KF, Shulman GI, Yki-Järvinen H, Luukkonen PK 2026 · J Hepatol | RCT | mixed | high | RCT found ketogenic and non-ketogenic weight-loss diets reduced intrahepatic triglycerides similarly, indicating benefit is weight-loss-driven not ketosis-specific. |
| Zou J, Tian F, Cui S, Hou J, Li Z, Wei Y, Cui H, Li Y, Zhou S, He Z, Ma X 2025 · BMC Gastroenterol | meta-analysis | tested-null | low | Network meta-analysis of MAFLD diets found Mediterranean/IF/DASH improve liver function without keto ranking as uniquely superior. |
| Mardinoglu A, Wu H, Bjornson E, Zhang C, Hakkarainen A, Räsänen SM, Lee S, Mancina RM, Bergentall M, Pietiläinen KH, Söderlund S, Matikainen N, Ståhlman M, Bergh PO, Adiels M, Piening BD, Granér M, Lundbom N, Williams KJ, Romeo S, Nielsen J, Snyder M, Uhlén M, Bergström G, Perkins R, Marschall HU, Bäckhed F, Taskinen MR, Borén J 2018 · Cell Metab | n-of-1 | supports | moderate | Isocaloric low-carbohydrate diet produced rapid liver-fat reduction with decreased de novo lipogenesis in obese NAFLD subjects. |
| Wang H, Ma Q, Chen Y, Luo L, Ye J, Zhong B 2024 · Obesity Reviews | observational | mixed | moderate | Network meta-analysis of 174 RCTs (n=10,183) comparing diet, exercise, and pharmacological interventions for NAFLD using endpoints including MRI-PDFF-based steatosis score; GLP-1 receptor agonists ranked best for liver-fat/steatosis improve |
| Farrell AM, Paris T, Parr EB, George ES, Howell J, Croagh C, Sutherland T, Page M, McKelvie P, Thompson AJ, Ryan M 2026 · J Hepatol Rep | RCT | supports | moderate | Randomized pilot in overweight/obese MASLD patients: very-low-energy ketogenic diet produced superior hepatic steatosis reduction vs Mediterranean diet. |
| You Y, Ni H, Ma Q, Jiang L, Cai J, He W, Lin X, Li K, Wang Z, Yan W, Xiao X, Ma L 2025 · Nutrition & diabetes | animal | supports | moderate | 2-wk KD in HFD-induced MASLD mice: reduced hepatic fat, ALT/AST; improved mitochondrial dynamics (Fis1/Drp1 down, ATP up) vs HFD control |
| Garbow JR, Doherty JM, Schugar RC, Travers S, Weber ML, Wentz AE, Ezenwajiaku N, Cotter DG, Brunt EM, Crawford PA 2011 · Am J Physiol Gastrointest Liver Physiol | animal | contradicts | low | Long-term ketogenic diet in mice caused hepatic steatosis, ER stress and injury. |
| Sun K, Li W, Chen Y, Nelson EAS, Chen X, Hui LL 2025 · Cell & bioscience | observational | supports | low | Narrative review: short-to-medium term KD ameliorates hepatic steatosis/steatohepatitis/fibrosis; more effective than calorie-matched high-carb low-fat diets short-term |
| Jornayvaz FR, Jurczak MJ, Lee HY, Birkenfeld AL, Frederick DW, Zhang D, Zhang XM, Samuel VT, Shulman GI 2010 · Am J Physiol Endocrinol Metab | animal | contradicts | low | Ketogenic diet in mice caused hepatic insulin resistance from increased hepatic diacylglycerol despite preventing weight gain. |
| Houttu V, Csader S, Nieuwdorp M, Holleboom AG, Schwab U 2021 · Front Nutr | meta-analysis | tested-null | low | Meta-analysis of dietary interventions found macronutrient interventions reduce liver fat, largely mediated by weight loss. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.